These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 36230957)

  • 21. What is the evidence that tau pathology spreads through prion-like propagation?
    Mudher A; Colin M; Dujardin S; Medina M; Dewachter I; Alavi Naini SM; Mandelkow EM; Mandelkow E; Buée L; Goedert M; Brion JP
    Acta Neuropathol Commun; 2017 Dec; 5(1):99. PubMed ID: 29258615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
    Catania M; Di Fede G
    Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies.
    Annadurai N; De Sanctis JB; Hajdúch M; Das V
    Exp Neurol; 2021 Sep; 343():113756. PubMed ID: 33989658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving prion-like tau conformers differentially alter postsynaptic proteins in neurons inoculated with distinct isolates of Alzheimer's disease tau.
    Hromadkova L; Kim C; Haldiman T; Peng L; Zhu X; Cohen M; de Silva R; Safar JG
    Cell Biosci; 2023 Sep; 13(1):174. PubMed ID: 37723591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau strains shape disease.
    Vaquer-Alicea J; Diamond MI; Joachimiak LA
    Acta Neuropathol; 2021 Jul; 142(1):57-71. PubMed ID: 33830330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different tau fibril types reduce prion level in chronically and de novo infected cells.
    Celauro L; Burato A; Zattoni M; De Cecco E; Fantuz M; Cazzaniga FA; Bistaffa E; Moda F; Legname G
    J Biol Chem; 2023 Aug; 299(8):105054. PubMed ID: 37454740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer's disease.
    Kim C; Haldiman T; Kang SG; Hromadkova L; Han ZZ; Chen W; Lissemore F; Lerner A; de Silva R; Cohen ML; Westaway D; Safar JG
    Sci Transl Med; 2022 Jan; 14(626):eabg0253. PubMed ID: 34985969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.
    Woerman AL; Patel S; Kazmi SA; Oehler A; Freyman Y; Espiritu L; Cotter R; Castaneda JA; Olson SH; Prusiner SB
    JAMA Neurol; 2017 Dec; 74(12):1464-1472. PubMed ID: 29059326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    Oakley DH; Klickstein N; Commins C; Chung M; Dujardin S; Bennett RE; Hyman BT; Frosch MP
    J Neurosci; 2021 May; 41(19):4335-4348. PubMed ID: 33893219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteopathic Strains and the Heterogeneity of Neurodegenerative Diseases.
    Walker LC
    Annu Rev Genet; 2016 Nov; 50():329-346. PubMed ID: 27893962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aβ and Tau Prions Causing Alzheimer's Disease.
    Condello C; Merz GE; Aoyagi A; DeGrado WF; Prusiner SB
    Methods Mol Biol; 2023; 2561():293-337. PubMed ID: 36399277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases.
    Kabir ME; Safar JG
    Prion; 2014; 8(1):111-6. PubMed ID: 24401672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion-Like Propagation of Post-Translationally Modified Tau in Alzheimer's Disease: A Hypothesis.
    Sonawane SK; Chinnathambi S
    J Mol Neurosci; 2018 Aug; 65(4):480-490. PubMed ID: 29982964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guam ALS-PDC is a distinct double-prion disorder featuring both tau and Aβ prions.
    Condello C; Ayers JI; Dalgard CL; Garcia Garcia MM; Rivera BM; Seeley WW; Perl DP; Prusiner SB
    Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2220984120. PubMed ID: 36952379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant Mammalian Prions: The "Correctly" Misfolded Prion Protein Conformers.
    Ma J; Zhang J; Yan R
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.